An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions (Q45877040)

17 December 2017

title

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions (English)

1 reference

17 December 2017

1 reference

C-H Nam

1

1 reference

17 December 2017

M N Lobato

2

1 reference

17 December 2017

A Appert

3

1 reference

17 December 2017

L F Drynan

4

1 reference

17 December 2017

T Tanaka

5

1 reference

17 December 2017

T H Rabbitts

6

1 reference

17 December 2017

language of work or name

English

0 references

publication date

28 April 2008

1 reference

17 December 2017

published in

Oncogene

1 reference

17 December 2017

volume

27

1 reference

17 December 2017

page(s)

4962-4968

1 reference

17 December 2017

issue

36

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/onc.2008.130

exact match

0 references

cites work

Recent progress in dendrimer-based nanocarriers.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Chromosomal translocation engineering to recapitulate primary events of human cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

By-passing selection: direct screening for antibody-antigen interactions using protein arrays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Nanocarriers as an emerging platform for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.130

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.130

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017